CELULARITY

celularity-logo

Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placentaโ€™s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

#SimilarOrganizations #People #Financial #Website #More

CELULARITY

Social Links:

Industry:
Biotechnology Health Care Therapeutics Wellness

Founded:
2017-09-01

Address:
Florham Park, New Jersey, United States

Country:
United States

Website Url:
http://www.celularity.com

Total Employee:
101+

Status:
Active

Contact:
908-768-2170

Email Addresses:
[email protected]

Total Funding:
400 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

robert-j-hariri_image

Robert J. Hariri Founder & Chairman @ Celularity
Board_member

peter-diamandis_image

Peter Diamandis Co-founder & Vice Chiarman @ Celularity
Board_member

not_available_image

Jay Bloom Board Member @ Celularity
Board_member

robin-l-smith_image

Robin L. Smith Board Member @ Celularity
Board_member

dean-kehler_image

Dean Kehler Board Member @ Celularity
Board_member

andrew-von-eschenbach_image

Andrew von Eschenbach Board Member @ Celularity
Board_member

tan-thay_image

Tan Thay Board Member @ Celularity
Board_member

marc-mazur_image

Marc Mazur Board Member @ Celularity
Board_member

Current Employees Featured

robert-j-hariri_image

Robert J. Hariri
Robert J. Hariri Founder, Chairperson, and Chief Executive Officer @ Celularity
Founder, Chairperson, and Chief Executive Officer
2016-10-01

john-r-haines_image

John R Haines
John R Haines Executive Vice President and Chief Operations & Administrative Officer @ Celularity
Executive Vice President and Chief Operations & Administrative Officer
2017-02-01

not_available_image

David C. Beers
David C. Beers Chief Financial Officer @ Celularity
Chief Financial Officer
2020-01-01

bradley-glover_image

Bradley Glover
Bradley Glover Executive Vice President and Chief Technology Officer @ Celularity
Executive Vice President and Chief Technology Officer

sharmila-koppisetti_image

Sharmila Koppisetti
Sharmila Koppisetti Vice President, Drug Safety/Pharmacovigilance @ Celularity
Vice President, Drug Safety/Pharmacovigilance

ankur-k-garg_image

Ankur K Garg
Ankur K Garg Executive Director, Brand & Content Strategy @ Celularity
Executive Director, Brand & Content Strategy
2020-04-01

not_available_image

Stephen A. Brigido, Chairman, SAB
Stephen A. Brigido, Chairman, SAB President- Functional Regeneration @ Celularity
President- Functional Regeneration

adam-keuhn_image

Adam Keuhn
Adam Keuhn Senior Medical Director @ Celularity
Senior Medical Director

anne-jones_image

Anne Jones
Anne Jones Executive Vice President and Chief Business Officer @ Celularity
Executive Vice President and Chief Business Officer

not_available_image

Beth Steinbrenner
Beth Steinbrenner Executive Vice President Human Resources @ Celularity
Executive Vice President Human Resources

Founder


peter-diamandis_image

Peter Diamandis

robert-j-hariri_image

Robert J. Hariri

Stock Details


Company's stock symbol is NASDAQ:CELU

Acquisitions List

Date Company Article Price
2018-08-31 Caricord Caricord acquired by Celularity N/A

Investors List

sorrento-therapeutics_image

Sorrento Therapeutics

Sorrento Therapeutics investment in Post-IPO Equity - Celularity

dragasac-limited_image

Dragasac Limited

Dragasac Limited investment in Post-IPO Equity - Celularity

starr-insurance-companies_image

Starr Insurance Companies

Starr Insurance Companies investment in Post-IPO Equity - Celularity

section-32_image

Section 32

Section 32 investment in Venture Round - Celularity

celgene_image

Celgene

Celgene investment in Venture Round - Celularity

heritage-group_image

Heritage Group

Heritage Group investment in Venture Round - Celularity

tony-robbins_image

Tony Robbins

Tony Robbins investment in Venture Round - Celularity

bill-maris_image

Bill Maris

Bill Maris investment in Venture Round - Celularity

united-therapeutics-unither_image

United Therapeutics

United Therapeutics investment in Venture Round - Celularity

human-longevity_image

Human Longevity

Human Longevity investment in Venture Round - Celularity

Official Site Inspections

http://www.celularity.com Semrush global rank: 2.26 M Semrush visits lastest month: 8.43 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Celularity" on Search Engine